CN1569102A - Medicine for treating bronchodilatation - Google Patents
Medicine for treating bronchodilatation Download PDFInfo
- Publication number
- CN1569102A CN1569102A CNA2004100090470A CN200410009047A CN1569102A CN 1569102 A CN1569102 A CN 1569102A CN A2004100090470 A CNA2004100090470 A CN A2004100090470A CN 200410009047 A CN200410009047 A CN 200410009047A CN 1569102 A CN1569102 A CN 1569102A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- rhizoma
- herba
- bronchiectasic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 65
- 229940079593 drug Drugs 0.000 title claims description 16
- 230000007883 bronchodilation Effects 0.000 title abstract 2
- 239000000843 powder Substances 0.000 claims abstract description 19
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 238000002347 injection Methods 0.000 claims description 14
- 239000007924 injection Substances 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 14
- 239000009636 Huang Qi Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 239000002775 capsule Substances 0.000 claims description 12
- 238000007796 conventional method Methods 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 11
- 241000208340 Araliaceae Species 0.000 claims description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 9
- 235000008434 ginseng Nutrition 0.000 claims description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 241000331528 Chlorophytum capense Species 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 7
- 241000180649 Panax notoginseng Species 0.000 claims description 7
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 7
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 7
- 235000013351 cheese Nutrition 0.000 claims description 6
- 230000003169 placental effect Effects 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241000605447 Anemarrhena Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 240000007371 Cuscuta campestris Species 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 241000229179 Ledebouriella Species 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 240000003582 Platycodon grandiflorus Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 229930191283 anemarrhena Natural products 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 201000009267 bronchiectasis Diseases 0.000 description 17
- 210000003734 kidney Anatomy 0.000 description 15
- 208000006673 asthma Diseases 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 12
- 208000000616 Hemoptysis Diseases 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 201000006306 Cor pulmonale Diseases 0.000 description 8
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 8
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 206010036790 Productive cough Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 239000003172 expectorant agent Substances 0.000 description 6
- 230000003419 expectorant effect Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 206010014561 Emphysema Diseases 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 230000002685 pulmonary effect Effects 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 229960002117 triamcinolone acetonide Drugs 0.000 description 5
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 230000002035 prolonged effect Effects 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 206010061245 Internal injury Diseases 0.000 description 2
- 208000037656 Respiratory Sounds Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000007124 immune defense Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010039109 Rhonchi Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 238000013276 bronchoscopy Methods 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229940124452 immunizing agent Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 208000005069 pulmonary fibrosis Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a medicine for treating bronchodilatation, characterized that it is prepared from root of balloonflower, cordate houttuynia, clam powder, lily bulb, schisandra fruit, American ginseng, cassia twig, gen-seng, ophiopogon root, raw astragalus root, ledebouriella root, white atractylodes rhizome, rhizoma dioscoreae, wolferry fruit, prepared rhizome of rehmannia, dodder seed, pinellia tuber, anemarrhena rhizome, root bark of chinese wolf berry.
Description
Technical field
The present invention relates to the bronchiectasic medicine of a cover treatment, specifically it is to be the Chinese medicine made according to a conventional method of raw material with the Chinese herbal medicine and the bronchiectasic medicine of a cover treatment of the Western medicine associating of acupoint injection therapy, genus field of medicaments.
Background technology
Bronchiectasis is common chronic bronchial purulent disease, and pilosity is born in child, teenager, man more than the woman.Clinical manifestation is with the recurrent cough, a large amount of purulent sputums, and intermittent hemoptysis, often concurrent infection is a principal character, outbreak repeatedly, obstinate is easily sent out emphysema, pulmonary heart disease etc.
Bronchiectasis belongs to categories such as the cough, expectoration, hemoptysis, lung abscess of the traditional Chinese medical science.The successive dynasties literature record, chronic cough must hemoptysis.Bronchial tissue on every side forms inflammation and increases the weight of gradually, causes respiratory failure, pulmonary heart disease at last, even dead.Because of the six climate exopathogens exopathogen soak attack or appetite, emotion, fatigue, suffer from cold, internal injury due to the prolonged illness.Evil lung qi, the impaired depurative descending of lung QI violated, the not main gas of lung of a specified duration, failure of the kidney in receiving QI, spleen is got involved.
At present clinical treatment based on antiinflammatory, reduce phlegm, relieving asthma, or excision, its therapeutic effect is all undesirable, the patient who has relies on medicine to produce Drug resistance all the year round, and outbreak makes the patient immune function low repeatedly, visceral dysfunction, the resisting cold ability, so this kind disease is very thorny in treatment.
Summary of the invention
Purpose of the present invention provides a cover just for the problem that solves above-mentioned existence be that the Chinese medicine that raw material is made is treated bronchiectasic medicine with a cover of acupoint injection therapy Western medicine with the Chinese herbal medicine, thereby can treat this kind disease effectively, reduce and remove patient's misery.
The objective of the invention is to realize by following technical proposal:
The bronchiectasic medicine of one cover treatment is made up of Chinese medicine and Western medicine, and it is to carry out decocting according to a conventional method by following raw materials by weight proportions to it is characterized in that described Chinese medicine, the capsule that its extracting solution is made through concentrated, dry powder process:
Radix Platycodonis 8-12 part Herba Houttuyniae 25-30 part sea clam powder 15-25 part Radix Stemonae 15-50 part
Bulbus Lilii 15-25 part Fructus Schisandrae Chinensis 8-10 part Radix Panacis Quinquefolii 15-20 part Ramulus Cinnamomi 8-10 part
Radix Ginseng 8-12 part Radix Ophiopogonis 10-20 part Radix Astragali 50-60 part Radix Saposhnikoviae 10-20 part
Rhizoma Atractylodis Macrocephalae 15-25 part RHIIZOMA DIOSCOREAE frOm Henan of China 15-18 part Fructus Lycii 8-12 part Radix Rehmanniae Preparata 10-15 part
Semen Cuscutae 18-22 part Rhizoma Pinelliae Preparatum 8-12 part Poria 15-20 part bracketplant 30-35 part
Radix Ranunculi Ternati 10-20 part Rhizoma Anemarrhenae 10-20 part Cortex Phellodendri 10-15 part Cortex Lycii 10-20 part,
Described Western medicine is nuclear cheese, placental fluids and Radix Astragali injection.
Also can add Herba Ephedrae 10-12 part, Fructus Psoraleae 8-10 part, Herba Asari 2-3 part, Gypsum Fibrosum 12-15 part, Cortex Mori 8-12 part, Flos Farfarae 10-12 part, Radix Glycyrrhizae 10-15 part, Radix Morindae Officinalis 10-15 part and Pseudobulbus Bletillae (Rhizoma Bletillae) 8-10 part in the crude drug at Chinese medicine when the concurrent bronchial asthma of bronchiectasis; Also can add Herba Ecliptae 25-35 part, Radix Cirsii Japonici 8-10 part, Herba Cirsii 8-10 part, Radix Notoginseng 8-12 part and Pseudobulbus Bletillae (Rhizoma Bletillae) 8-10 part in the crude drug at Chinese medicine when bronchiectasis generation hemoptysis, when concurrent bronchial asthma can be used Triamcinolone Acetonide.
Chinese medicine of the present invention is according to the crude drug of theory of Chinese medical science and the selection of clinical experience for many years and prescription, with the Chinese medicine and western medicine treating both the principal and secondary aspects of a disease, alleviating the back effects a permanent cure based on Chinese medicine, treat Radix Platycodonis in the bronchiectasic prescription, Herba Houttuyniae, the sea clam powder, Fructus Schisandrae Chinensis, Radix Panacis Quinquefolii, Radix Astragali, Radix Saposhnikoviae, the Rhizoma Atractylodis Macrocephalae, Semen Cuscutae is a monarch drug, the Radix Stemonae, Bulbus Lilii, Ramulus Cinnamomi, Radix Ginseng, Radix Ophiopogonis, RHIIZOMA DIOSCOREAE frOm Henan of China, Fructus Lycii, Radix Rehmanniae Preparata, Poria, bracketplant is ministerial drug, Rhizoma Pinelliae Preparatum, Cortex Phellodendri, Cortex Lycii is an adjuvant drug, remainder is a messenger drug, the pharmaceutical formulation epheday intermedia that adds during the concurrent bronchial asthma of bronchiectasis is monarch drug, Fructus Psoraleae, Herba Asari, Cortex Mori, Radix Glycyrrhizae, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Morindae Officinalis is a ministerial drug, Gypsum Fibrosum, Flos Farfarae is an adjuvant drug, Herba Ecliptae in the pharmaceutical formulation that adds during bronchiectasis generation hemoptysis, Radix Cirsii Japonici, Herba Cirsii, the Pseudobulbus Bletillae (Rhizoma Bletillae) is a monarch drug, and Radix Notoginseng is a ministerial drug.
Bronchiectasic lung, each dirty functional disorder of kidney,spleen,liver, because of the six climate exopathogens exopathogen soak attack or appetite, emotion, fatigue, suffer from cold, internal injury due to the prolonged illness.The evil lung qi of violating, impaired depurative descending of lung QI, the not main gas of lung of a specified duration, failure of the kidney in receiving QI, spleen is got involved, cause a large amount of purulent sputums, hemoptysis, Radix Platycodonis in the side, Herba Houttuyniae, the sea clam powder, Radix Cirsii Japonici, Herba Cirsii, Radix Notoginseng, the Pseudobulbus Bletillae (Rhizoma Bletillae) and Herba Ecliptae have antiinflammatory, relieving asthma, the hemostatic effect, or prevent hemorrhage effect, the spleen being the source of producing phlegm, be the mother of lungs, the prolonged illness impairment of the spleen can not transmitting and distributing the fluids and is made humidogene expectorant, on store in lung, the Yong Sai air flue, aggravation is coughed, expectorant, breathe heavily Rhizoma Pinelliae Preparatum in the side, Fructus Schisandrae Chinensis, Poria, but dispelling phlegm and eliminating dampness, the liver belonging to wood, wood can be lit a fire, prolonged illness impairing the liver, liver-fire are pented up the formation blood stasis, and be damp and hot not following, expectorant is given birth in pent-up, kidney governing inspiration is coughed for a long time and then is impairment of the kidney, RHIIZOMA DIOSCOREAE frOm Henan of China, Fructus Lycii, Semen Cuscutae, has nourishing kidney water function, the enhancing human body immunity function, kidney governing inspiration is coughed for a long time and then is impairment of the kidney, and kidney is taken the photograph not normal, then breathe heavily, cough and increase the weight of, lung, spleen, kidney is got involved, Fructus Psoraleae, Radix Morindae Officinalis, Semen Cuscutae, Radix Panacis Quinquefolii, Fructus Lycii and Radix Rehmanniae Preparata all have the adrenal cortex reinforcing function, are the methods of effecting a permanent cure.
Because the most of innate immunity hypofunction of bronchiectasis patient, the clothing, food, lodging and transportion--basic necessities of life of living are not at ordinary times noted, be subjected to the just morbidity of invasion and attack of exopathogen six climate exopathogens, but adopt Radix Saposhnikoviae, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Astragali, Ramulus Cinnamomi spleen reinforcing in the side, improve patient's immunity of organisms, prevent flu, prevent repeated infection, prevent that the patient is attacked by exopathogen, avoid bronchiectasis to acute development.Bronchiectasis develops into emphysema, pulmonary heart disease, decrease in the arteries and veins of main gas dirty, cause gas not transport blood, the blood vessels retardance, form the disease of blood stasis, so adopt Ramulus Cinnamomi, but Radix Stemonae removing blood stasis is invigorated blood circulation, blood vessel dilating, logical blood flow relaxes, the kidney invigorating, Bulbus Lilii, the Radix Ginseng the kidney warming reduces phlegm, the Radix Ophiopogonis yin nourishing is reduced phlegm, cooperate Radix Ginseng, Fructus Schisandrae Chinensis can increase the heartbeat effect, the bracketplant may command infects clear interior-heat, removing fire from the liver, Radix Ranunculi Ternati treatment interior-heat caused by deficiency of YIN, Cortex Lycii and the replenishing YIN and removing heat of Rhizoma Anemarrhenae adjustable and balancing, the Cortex Phellodendri antiphlogistic antibacterial, the Rhizoma Anemarrhenae also has therapeutical effect to hectic fever due to YIN-deficiency consumptive disease heat, want treating both the principal and secondary aspects of a disease to cooperate acupoint injection therapy by clinical practice, reconcile zang-fu disharmony with immunizing agent, Yin Yang balancing, improve pathological change, full side has the kidney invigorating lung benefiting, the suppressing the hyperactive liver pathogenic fire purging, antiinflammatory is relievingd asthma, reduce phlegm, blood circulation promoting and blood stasis dispelling, strengthening the body resistance, coordinate mutually, all ways raising immune defense function of reaching the same goal improves function and reaches healthy recovery from illness.
But the pharmaceutical formulation epheday intermedia, Herba Asari, the Cortex Mori Zhichuan that add during the concurrent bronchial asthma of bronchiectasis, the Gypsum Fibrosum heat clearing away, the Flos Farfarae expectorant and asthma-curing, the Radix Glycyrrhizae cough-relieving, Radix Morindae Officinalis, Pseudobulbus Bletillae (Rhizoma Bletillae) reinforcing the kidney and arresting hemorrhage Fructus Psoraleae have the kidney invigorating effect, and Herba Ecliptae in the pharmaceutical formulation that adds during bronchiectasis generation hemoptysis, Radix Cirsii Japonici, Herba Cirsii, the Pseudobulbus Bletillae (Rhizoma Bletillae) are to can stop blooding removing heat from blood or prevent hemorrhage of acute stage.
Medicine of the present invention is obtained excellent curative through for many years clinical observation, and its result is as follows:
Clinical report
Patient's 100 examples, male 60 examples, women 40 examples, age 20-66 year, the course of disease is the longest 30 years, and is the shortest 5 years, wherein merges coronary heart disease 25 examples, merges emphysema 20 examples, merges pulmonary heart disease 15 examples, pulmonary fibrosis 5 examples,
Diagnosis basis
1, from childhood or young stage morbidity, long-term cough is arranged, a large amount of purulent sputum, classical symptoms such as hemoptysis and pulmonary infection repeatedly.
2, history of repeated attack for many years, the light winter in summer is heavy, and with the passing of time the state of an illness coughs throughout the year, and vomiting pus expectorant is unable, the performance of body constitution extremely feeble.
3, primary disease should with chronic bronchitis, pulmonary tuberculosis,, pulmonary abscess, congenital pulmonary cyst etc. are sick differentiates.
4, sign: pulmonary has persistence to have the local infection focus, moist rale, rhonchi, and drumstick finger.
5, X line bronchography, CT or fiberoptic bronchoscopy: corresponding pathological change is arranged, and part has fibrosis, emphysema, diaphram is sagging.
6, electrocardiogram: concurrent emphysema, pulmonary type p ripple, pulmonary heart disease, clockwise rotation.
The treatment standard:
Judge mark Huaihe River according to national bronchiectasis specialized conference analysis of cases curative effect in 1977, in conjunction with self calibration Huaihe River: the X ray examination infects all and disappears, and does not recur in 2 years operate as normal to be recovery from illness, and sx is for taking a turn for the better, do not have before and after the treatment change into invalid.
Therapeutic Method:
1, oral medicament capsule of the present invention, every 0.25g, each 4-6 grain, every day 3 times, the person of being in a bad way uses antibiotic based on decoction during acute attack, the concurrent pulmonary heart disease of anoxia is arranged, give quiet the pushing away of cytochromeC3 0mg+25% glucose 60ml, 2-3 time on the one, concurrent diabetes physiological salt liquid.
2, acupoint injection therapy:
Injection: nuclear cheese, placental fluids and Radix Astragali injection.
Injecting method: conventional acupoint selection position Dingchuan, Danzhong, feishu, tsu san li.Concurrent pulmonary heart disease
Add Xinshu cave, feishu DINGCHUAN acupoint, cave, Shenshu cave.Each 2ml, every injection on the three once, concurrent bronchial asthma can be used Triamcinolone Acetonide, each 2ml, every injection on the three once.
Clinical observation result sees Table 1
Table 1 clinical observation statistical result
Age | 20-30 year | 31-40 year | 41-66 year |
Total case load | ????50 | ????34 | ????16 |
Sex | The men and women | The men and women | The men and women |
Case load | ????26????24 | ????25????9 | ????7????9 |
Cure routine number | ????13????12 | ????12????6 | ????4????5 |
Produce effects example number | ????10????10 | ????12????2 | ????2????3 |
Invalid routine number | ????3?????2 | ????1?????1 | ????1????1 |
Cure rate % | ????50.00% | ????52.94% | ????56.25% |
Obvious effective rate % | ????40.00% | ????41.18% | ????31.25% |
Inefficiency % | ????10.00% | ????5.88% | ????12.50% |
Total effective rate % | ????90.00% | ????94.12% | ????87.50% |
Typical case's case history
The king * *, the woman, 30 years old, the Pekinese, high heat cough, vomiting pus expectorant is bronchiectasis after diagnosing, the suggestion pneumonectomy of certain hospital, patient and family members disagree with, take medicine of the present invention in 98 years, treat 4 courses of treatment after, the X line shows: pulmonary infection disappears, and recurs so far.
The summer * *, man, 60 years old, Beijing Shunyi County people, suffered from bronchiectasis 30 years, once in Beijing, Tianjin Hospital treats, its poor effect, hyperpyrexia happens suddenly in February, 92, the vomiting pus fetid sputum has hemoptysis once in a while, is in hospital three months, the commentaries on classics of not getting better, general weakness, pale complexion, dyspnea is diagnosed as the bronchiectasis large-area fibreization and transfers pulmonary heart disease to, can not treat and leaves hospital, used Drug therapy of the present invention in 96 years, through 5 course of therapy recoveries from illness, not recurrence so far.
The king * *, the woman, 66 years old, the Pekinese was diagnosed as bronchiectasis, once in two tame hospitalizes, all do not take a turn for the better, the treatment through this medicine in 2000, fully recover two courses of treatment, so far not recurrence.
Zhao * *, the woman, 20 years old, people from Hebei suffered from bronchiectasis 10 years, once in Beijing, Tianjin Hospital's treatment do not have and takes a turn for the better, increased the weight of gradually in recent years, continuous hemoptysis, 96 years begin with three recoveries from illness courses of treatment of Drug therapy of the present invention, recurrence so far.
The Qin * *, the man, people from Heilungkiang, this patient was since cough in 2 years old, expectoration, abundant expectoration existing 30 years so far, through excessive, infirmary treats for many years, there is no effect, calendar year 2001 comes institute with 4 courses of treatment of Drug therapy of the present invention from the native place, Heilungkiang, after X-ray examination pathology recovers normally substantially, recur so far after leaving hospital.
Compared with the prior art the technology of the present invention has following advantage and effect:
A) medicine of the present invention is with the Chinese medicine and western medicine treating both the principal and secondary aspects of a disease, alleviating that the back effects a permanent cure with Chinese medicine serves as mainly to cooperate that acupoint injection therapy has that the kidney invigorating lung benefiting, suppressing the hyperactive liver pathogenic fire purging, antiinflammatory are relievingd asthma, reduced phlegm, blood circulation promoting and blood stasis dispelling, strengthening the body resistance, coordinate all ways raising immune defense function of reaching the same goal mutually, improve function and reach healthy recovery from illness
B) therapeutic effect is good, have no side effect,
C) raw material is easy to get, and compatibility is reasonable.
The specific embodiment
Embodiment 1
Get Radix Platycodonis 8kg, Herba Houttuyniae 30kg, sea clam powder 15kg, Radix Stemonae 20kg, Bulbus Lilii 15kg, Fructus Schisandrae Chinensis 10kg, Radix Panacis Quinquefolii 15kg, Ramulus Cinnamomi 10kg, Radix Ginseng 8kg, Radix Ophiopogonis 20kg, Radix Astragali 50kg, Radix Saposhnikoviae 20kg, Rhizoma Atractylodis Macrocephalae 15kg, RHIIZOMA DIOSCOREAE frOm Henan of China 18kg, Fructus Lycii 8kg, Radix Rehmanniae Preparata 15kg, Semen Cuscutae 18kg, Rhizoma Pinelliae Preparatum 12kg, Poria 15kg, bracketplant 35kg, Radix Ranunculi Ternati 10kg, Rhizoma Anemarrhenae 20kg, Cortex Phellodendri 10kg and Cortex Lycii 20kg, to carry out decocting according to a conventional method after the mixing of above-mentioned raw materials medicine, its extracting solution is made capsule through concentrated, dry powder process.
Cooperate nuclear cheese, placental fluids and Radix Astragali injection during treatment, concurrent bronchial asthma can be used Triamcinolone Acetonide.
Embodiment 2
Get Radix Platycodonis 10kg, Herba Houttuyniae 28kg, sea clam powder 20kg, Radix Stemonae 18kg, Bulbus Lilii 20kg, Fructus Schisandrae Chinensis 9kg, Radix Panacis Quinquefolii 18kg, Ramulus Cinnamomi 9kg, Radix Ginseng 10kg, Radix Ophiopogonis 15kg, Radix Astragali 55kg, Radix Saposhnikoviae 15kg, Rhizoma Atractylodis Macrocephalae 20kg, RHIIZOMA DIOSCOREAE frOm Henan of China 17kg, Fructus Lycii 10kg, Radix Rehmanniae Preparata 12kg, Semen Cuscutae 20kg, Rhizoma Pinelliae Preparatum 10kg, Poria 18kg, bracketplant 32kg, Radix Ranunculi Ternati 15kg, Rhizoma Anemarrhenae 15kg, Cortex Phellodendri 12kg and Cortex Lycii 15kg, to carry out decocting according to a conventional method after the mixing of above-mentioned raw materials medicine, its extracting solution is made capsule through concentrated, dry powder process.
Cooperate nuclear cheese, placental fluids and Radix Astragali injection during treatment, concurrent bronchial asthma can be used Triamcinolone Acetonide.
Embodiment 3
Get Radix Platycodonis 12kg, Herba Houttuyniae 25kg, sea clam powder 25kg, Radix Stemonae 15kg, Bulbus Lilii 25kg, Fructus Schisandrae Chinensis 8kg, Radix Panacis Quinquefolii 20kg, Ramulus Cinnamomi 8kg, Radix Ginseng 12kg, Radix Ophiopogonis 10 kg, Radix Astragali 60kg, Radix Saposhnikoviae 10kg, Rhizoma Atractylodis Macrocephalae 25kg, RHIIZOMA DIOSCOREAE frOm Henan of China 15kg, Fructus Lycii 12kg, Radix Rehmanniae Preparata 10kg, Semen Cuscutae 22kg, Rhizoma Pinelliae Preparatum 8kg, Poria 20kg, bracketplant 30kg, Radix Ranunculi Ternati 20kg, Rhizoma Anemarrhenae 10kg, Cortex Phellodendri 15kg and Cortex Lycii 10kg, to carry out decocting according to a conventional method after the mixing of above-mentioned raw materials medicine, its extracting solution is made capsule through concentrated, dry powder process.
Cooperate nuclear cheese, placental fluids and Radix Astragali injection during treatment, concurrent bronchial asthma can be used Triamcinolone Acetonide.
Embodiment 4
In embodiment 1, add Herba Ephedrae 10kg, Fructus Psoraleae 10kg, Herba Asari 2kg, Gypsum Fibrosum 15kg, Cortex Mori 8kg, Flos Farfarae 12kg, Radix Glycyrrhizae 10kg, Radix Morindae Officinalis 15kg and Pseudobulbus Bletillae (Rhizoma Bletillae) 8kg, the above-mentioned raw materials medicine carries out decocting after mixing according to a conventional method, and its extracting solution is made capsule through concentrated, dry powder process.
Embodiment 5
In embodiment 2, add Herba Ephedrae 11kg, Fructus Psoraleae 9kg, Herba Asari 2.5kg, Gypsum Fibrosum 13kg, Cortex Mori 10kg, Flos Farfarae 11kg, Radix Glycyrrhizae 13kg, Radix Morindae Officinalis 13kg and Pseudobulbus Bletillae (Rhizoma Bletillae) 9kg, the above-mentioned raw materials medicine carries out decocting after mixing according to a conventional method, and its extracting solution is made capsule through concentrated, dry powder process.
Embodiment 6
In embodiment 3, add Herba Ephedrae 12kg, Fructus Psoraleae 8kg, Herba Asari 3kg, Gypsum Fibrosum 12kg, Cortex Mori 12kg, Flos Farfarae 10kg, Radix Glycyrrhizae 15kg, Radix Morindae Officinalis 10kg and Pseudobulbus Bletillae (Rhizoma Bletillae) 10kg, the above-mentioned raw materials medicine carries out decocting after mixing according to a conventional method, and its extracting solution is made capsule through concentrated, dry powder process.
Embodiment 7
Add Herba Ecliptae 25kg, Radix Cirsii Japonici 10kg, Herba Cirsii 8kg, Radix Notoginseng 12kg and Pseudobulbus Bletillae (Rhizoma Bletillae) 10kg in embodiment 1, the above-mentioned raw materials medicine carries out decocting after mixing according to a conventional method, and its extracting solution is made capsule through concentrated, dry powder process.
Embodiment 8
Add Herba Ecliptae 30kg, Radix Cirsii Japonici 9kg, Herba Cirsii 9kg, Radix Notoginseng 10kg and Pseudobulbus Bletillae (Rhizoma Bletillae) 9kg in embodiment 2, the above-mentioned raw materials medicine carries out decocting after mixing according to a conventional method, and its extracting solution is made capsule through concentrated, dry powder process.
Embodiment 9
Add Herba Ecliptae 35kg, Radix Cirsii Japonici 8kg, Herba Cirsii 10kg, Radix Notoginseng 8kg and Pseudobulbus Bletillae (Rhizoma Bletillae) 8kg in embodiment 3, the above-mentioned raw materials medicine carries out decocting after mixing according to a conventional method, and its extracting solution is made capsule through concentrated, dry powder process.
Claims (4)
1, the bronchiectasic medicine of a cover treatment is made up of Chinese medicine and Western medicine, and it is to carry out decocting according to a conventional method by following raw materials by weight proportions to it is characterized in that described Chinese medicine, the capsule that its extracting solution is made through concentrated, dry powder process:
Radix Platycodonis 8-12 part Herba Houttuyniae 25-30 part sea clam powder 15-25 part Radix Stemonae 15-50 part
Bulbus Lilii 15-25 part Fructus Schisandrae Chinensis 8-10 part Radix Panacis Quinquefolii 15-20 part Ramulus Cinnamomi 8-10 part
Radix Ginseng 8-12 part Radix Ophiopogonis 10-20 part Radix Astragali 50-60 part Radix Saposhnikoviae 10-20 part
Rhizoma Atractylodis Macrocephalae 15-25 part RHIIZOMA DIOSCOREAE frOm Henan of China 15-18 part Fructus Lycii 8-12 part Radix Rehmanniae Preparata 10-15 part
Semen Cuscutae 18-22 part Rhizoma Pinelliae Preparatum 8-12 part Poria 15-20 part bracketplant 30-35 part
Radix Ranunculi Ternati 10-20 part Rhizoma Anemarrhenae 10-20 part Cortex Phellodendri 10-15 part Cortex Lycii 10-20 part,
Described Western medicine is nuclear cheese, placental fluids and Radix Astragali injection.
2, the bronchiectasic medicine of treatment according to claim 1 is characterized in that also can adding Herba Ephedrae 10-12 part, Fructus Psoraleae 8-10 part, Herba Asari 2-3 part, Gypsum Fibrosum 12-15 part, Cortex Mori 8-12 part, Flos Farfarae 10-12 part, Radix Glycyrrhizae 10-15 part, Radix Morindae Officinalis 10-15 part and Pseudobulbus Bletillae (Rhizoma Bletillae) 8-10 part in the crude drug of Chinese medicine.
3, the bronchiectasic medicine of treatment according to claim 1 is characterized in that also can adding Herba Ecliptae 25-35 part, Radix Cirsii Japonici 8-10 part, Herba Cirsii 8-10 part, Radix Notoginseng 8-12 part and Pseudobulbus Bletillae (Rhizoma Bletillae) 8-10 part in the crude drug of Chinese medicine.
4, the bronchiectasic medicine of treatment according to claim 1 is characterized in that the described Western medicine scorching relaxed and comfortable A that dispels in addition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100090470A CN1241631C (en) | 2004-04-27 | 2004-04-27 | Medicine for treating bronchodilatation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100090470A CN1241631C (en) | 2004-04-27 | 2004-04-27 | Medicine for treating bronchodilatation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1569102A true CN1569102A (en) | 2005-01-26 |
CN1241631C CN1241631C (en) | 2006-02-15 |
Family
ID=34477780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100090470A Expired - Fee Related CN1241631C (en) | 2004-04-27 | 2004-04-27 | Medicine for treating bronchodilatation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1241631C (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101181596B (en) * | 2007-11-28 | 2010-07-21 | 宋瑞芳 | Chinese medicine composition orally taken for curing bronchiolectasis |
CN102274402A (en) * | 2011-07-15 | 2011-12-14 | 黄静波 | Asthma and cough relieving powder |
CN102327525A (en) * | 2011-10-13 | 2012-01-25 | 上海中医药大学附属岳阳中西医结合医院 | Chinese medicinal composition for treating bronchiectasis |
CN103028027A (en) * | 2012-12-27 | 2013-04-10 | 青岛市市立医院 | Traditional Chinese medicine composition for treating bronchiectasis |
CN103495072A (en) * | 2013-10-25 | 2014-01-08 | 梁轶聪 | Traditional Chinese medicine composition treating bronchiectasia disease and preparation method thereof |
CN104547676A (en) * | 2014-12-25 | 2015-04-29 | 邹德奇 | Traditional Chinese medicinal composition for treating stable-phase bronchiectasis and preparation of composition |
CN107349303A (en) * | 2017-09-01 | 2017-11-17 | 上海中医药大学附属岳阳中西医结合医院 | A kind of Chinese medicine composition for treating chronic pectoralgia and its application |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102416096B (en) * | 2011-12-02 | 2013-07-31 | 香河县气管炎哮喘医院 | Traditional Chinese medicine for treating bronchiectasis |
-
2004
- 2004-04-27 CN CNB2004100090470A patent/CN1241631C/en not_active Expired - Fee Related
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101181596B (en) * | 2007-11-28 | 2010-07-21 | 宋瑞芳 | Chinese medicine composition orally taken for curing bronchiolectasis |
CN102274402A (en) * | 2011-07-15 | 2011-12-14 | 黄静波 | Asthma and cough relieving powder |
CN102327525A (en) * | 2011-10-13 | 2012-01-25 | 上海中医药大学附属岳阳中西医结合医院 | Chinese medicinal composition for treating bronchiectasis |
CN103028027A (en) * | 2012-12-27 | 2013-04-10 | 青岛市市立医院 | Traditional Chinese medicine composition for treating bronchiectasis |
CN103495072A (en) * | 2013-10-25 | 2014-01-08 | 梁轶聪 | Traditional Chinese medicine composition treating bronchiectasia disease and preparation method thereof |
CN103495072B (en) * | 2013-10-25 | 2014-12-03 | 陈中元 | Traditional Chinese medicine composition treating bronchiectasia disease and preparation method thereof |
CN104547676A (en) * | 2014-12-25 | 2015-04-29 | 邹德奇 | Traditional Chinese medicinal composition for treating stable-phase bronchiectasis and preparation of composition |
CN104547676B (en) * | 2014-12-25 | 2018-06-26 | 徐梅 | It is a kind of to treat stationary phase bronchiectasic Chinese medicine composition and its preparation |
CN107349303A (en) * | 2017-09-01 | 2017-11-17 | 上海中医药大学附属岳阳中西医结合医院 | A kind of Chinese medicine composition for treating chronic pectoralgia and its application |
CN107349303B (en) * | 2017-09-01 | 2020-05-05 | 上海中医药大学附属岳阳中西医结合医院 | A kind of traditional Chinese medicine composition for treating chronic chest pain and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1241631C (en) | 2006-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101116733A (en) | Medicinal pill for clearing away lung heat and treating pulmonary tuberculosis | |
CN102526674A (en) | Medicine for treating bronchitis and bronchial asthma suffered by children aging from three to seven | |
CN100998751B (en) | Traditional Chinese medicine decoction for treating radiation pneumonitis | |
CN111388582B (en) | Traditional Chinese medicine composition for treating novel coronavirus pneumonia and application of preparation thereof | |
CN107050338A (en) | Chinese medicine composition and preparation method for treating chronic pharyngitis | |
CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
CN100563693C (en) | A kind of Chinese medicine composition of orally taken for curing chronic bronchitis | |
CN103520680B (en) | The Chinese medicine for the treatment of acute heart failure | |
CN102727758B (en) | Traditional Chinese medicine enema for treating ulcerative colitis | |
CN1241631C (en) | Medicine for treating bronchodilatation | |
Lin et al. | A retrospective study on clinical features of and treatment methods for 77 severe cases of SARS | |
CN113274470B (en) | Traditional Chinese medicine composition for treating novel coronavirus pneumonia | |
CN105031445A (en) | Chinese medicinal composition for treating pulmonary tuberculosis | |
CN101062255A (en) | Decoction for treating asthma and so on | |
CN104306793A (en) | Chinese herba preparation for treating lobar pneumonia | |
CN105250408B (en) | A kind of traditional Chinese medicine composition for treating poultry adenovirus infection | |
CN101347595B (en) | Chinese medicine for treating rheumatic heart of children | |
CN111184805B (en) | Traditional Chinese medicine composition and application thereof | |
CN1443545A (en) | Medicine for curing acne and its preparation method | |
CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
CN1281257C (en) | Combination of Chinese herbal medicine for curing chronic tracheitis and chronic bronchitis | |
CN104940764A (en) | Traditional Chinese medicine composition preparation for treating pulmonary tuberculosis | |
CN104524289A (en) | Medicine composition for treating wind-warm lung-heat diseases | |
CN1269518C (en) | Compound medicine for treating tuberculosis and its preparing method | |
CN1159054C (en) | Tongfuzhixie preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060215 |